Gary A. Shangold - Concepedia

Author

Gary A. Shangold

University of Chicago

Also Known As

G A Shangold, G SHANGOLD, G Shangold, G. Shangold, GARY A. SHANGOLD, Gary A Shangold, Gary A. Shangold, Gary Shangold

Publications

Citations

H-Index

Concepts

All Affiliations

University of Chicago Johnson & Johnson (United States)Uppsala University Hospital University of Cincinnati Medical Center

About

Gary A. Shangold is an author at University of Chicago specializing in medicine, public health, and obstetrics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	18	1.2K
2	Public Health	13	13	1.1K
3	Health Sciences	1	1	11
4	Social Sciences	1	1	10
5	Applied Physiology	1	1	11

Gary A. Shangold

Publications

1.9K

Citations

H-Index

Page 1

	Year	Citations
An oxytocin receptor antagonist (atosiban) in the treatment of preterm labor: A randomized, double-blind, placebo-controlled trial with tocolytic rescue Roberto Romero, Baha M. Sibai, Luis Sanchez‐Ramos, American Journal of Obstetrics and Gynecology Oxytocin Receptor AntagonistPostpartum HemorrhagePreterm LaborMaternal ComplicationReproductive Health	2000	322
Contraceptive efficacy and cycle control with the Ortho Evra™/Evra™ transdermal system: the analysis of pooled data Miriam Zieman, John Guillebaud, Edith Weisberg, Fertility and Sterility	2002	295
Tranexamic Acid Treatment for Heavy Menstrual Bleeding Andrea S. Lukes, Keith A. Moore, Ken Muse, Obstetrics and Gynecology	2010	233
Maintenance treatment of preterm labor with the oxytocin antagonist atosiban Guillermo J. Valenzuela, Luis Sanchez‐Ramos, Roberto Romero, American Journal of Obstetrics and Gynecology Postpartum HemorrhagePreterm LaborPhysiologyGynecologyMaternal Health	2000	152
Assessment of compliance with a weekly contraceptive patch (Ortho Evra™/Evra™) among North American women David F. Archer, Alison Bigrigg, Geoffrey H Smallwood, Fertility and Sterility Pregnancy PreventionContraceptionContraceptive UseHormonal ContraceptiveSexual And Reproductive Health	2002	112
Prevention of Vaginal Trichomoniasis by Compliant Use of the Female Condom David E. Soper, Donna Shoupe, Gary A. Shangold, Sexually Transmitted Diseases	1993	104
A comparative and pooled analysis of the safety and tolerability of the contraceptive patch (Ortho Evra™/Evra™) Baha M. Sibai, Viveca Odlind, M Meador, Fertility and Sterility Contraceptive UseHormonal ContraceptiveFertilityOral ContraceptiveSterility	2002	103
Gonadotropin-releasing hormone-induced Ca2+ transients in single identified gonadotropes require both intracellular Ca2+ mobilization and Ca2+ influx. Gary A. Shangold, Shawn N. Murphy, R. J. Miller Proceedings of the National Academy of Sciences Single Identified GonadotropesGynecologyReproductive BiologyCellular PhysiologyReproductive Endocrinology	1988	91
Integrated summary of Ortho Evra™/Evra™ contraceptive patch adhesion in varied climates and conditions Howard A. Zacur, B. Hédon, Diana Mansour, Fertility and Sterility ContraceptionHormonal ContraceptiveFertilityReproductive HealthGynecology	2002	81
Ortho Evra™/Evra™ versus oral contraceptives: follicular development and ovulation in normal cycles and after an intentional dosing error Roger A. Pierson, David F. Archer, Michèle Moreau, Fertility and Sterility Intentional Dosing ErrorContraceptionHormonal ContraceptiveFertilityOral Contraceptives	2003	78

Page 1